Marella Thorell

Insider Reports History

Location
Ambler, PA
Signature
/s/ Marella Thorell
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Marella Thorell:

Company Role Class Num Shares Value Price $ Report Date Ownership
Centessa Pharmaceuticals plc Chief Accounting Officer Ordinary Shares 53,101 $422,684 $7.96 21 Mar 2022 Direct
Vallon Pharmaceuticals, Inc. Director Common Stock 9,506 $38,784 $4.08 13 Dec 2022 Direct
Evelo Biosciences, Inc. Chief Financial Officer Common Stock 22,259 $7,345 $0.3300 08 Nov 2023 Direct
ESSA Pharma Inc. Director Common Shares 0 $0 $0.2400 09 Oct 2025 Direct
Seres Therapeutics, Inc. EVP and Chief Financial Officer Stock Option (Right to Buy) 650,000 07 Feb 2025 Direct
Carisma Therapeutics Inc. Director Stock Option (Right to Buy) 38,700 01 Jul 2024 Direct
Evelo Biosciences, Inc. Chief Financial Officer Restricted Stock Units 6,500 07 Nov 2023 Direct

Insider Reports Filed by Marella Thorell

Symbol Company Period Transactions Value $ Form Type Role Filing Time
EPIX ESSA Pharma Inc. 09 Oct 2025 1 $0 4 Director 15 Oct 2025, 11:55
MCRB Seres Therapeutics, Inc. 07 Feb 2025 1 $0 4 EVP and Chief Financial Officer 11 Feb 2025, 16:15
CARM Carisma Therapeutics Inc. 01 Jul 2024 1 $0 4 Director 01 Jul 2024, 19:19
CARM Carisma Therapeutics Inc. 30 Jun 2024 0 $0 3 Director 01 Jul 2024, 19:16
EPIX ESSA Pharma Inc. 25 Mar 2024 1 $0 4 Director 28 Mar 2024, 12:40
MCRB Seres Therapeutics, Inc. 25 Mar 2024 1 $0 4 EVP and Chief Financial Officer 27 Mar 2024, 16:20
MCRB Seres Therapeutics, Inc. 25 Mar 2024 0 $0 3 EVP and Chief Financial Officer; Exhibit List: Exhibit 24 - Power of Attorney 27 Mar 2024, 16:15
EVLO Evelo Biosciences, Inc. 07 Nov 2023 3 -$598 4 Chief Financial Officer 08 Nov 2023, 20:31
EVLO Evelo Biosciences, Inc. 01 Nov 2023 3 -$1,320 4 Chief Financial Officer 03 Nov 2023, 16:11
EVLO Evelo Biosciences, Inc. 11 Sep 2023 1 $0 4 Chief Financial Officer 13 Sep 2023, 20:55
EVLO Evelo Biosciences, Inc. 07 Aug 2023 3 -$19,058 4 Chief Financial Officer 09 Aug 2023, 20:42
EVLO Evelo Biosciences, Inc. 08 May 2023 1 -$4,836 4 Chief Financial Officer 10 May 2023, 21:31
EVLO Evelo Biosciences, Inc. 07 May 2023 2 $0 4 Chief Financial Officer 09 May 2023, 16:09
EVLO Evelo Biosciences, Inc. 07 Feb 2023 1 $0 4 Chief Financial Officer 09 Feb 2023, 15:25
GRI Vallon Pharmaceuticals, Inc. 13 Dec 2022 1 $0 4 Director 15 Dec 2022, 15:26
EVLO Evelo Biosciences, Inc. 01 Sep 2022 1 $0 4 Chief Financial Officer 01 Sep 2022, 16:52
EVLO Evelo Biosciences, Inc. 13 Jul 2022 0 $0 3 Chief Financial Officer 18 Jul 2022, 16:22
GRI Vallon Pharmaceuticals, Inc. 01 Jul 2022 1 $0 4 Director 06 Jul 2022, 14:03
EPIX ESSA Pharma Inc. 29 Jun 2022 1 $0 4 Director 01 Nov 2022, 11:08
GRI Vallon Pharmaceuticals, Inc. 09 Jun 2022 1 $0 4 Director 10 Jun 2022, 13:31
CNTA Centessa Pharmaceuticals plc 21 Mar 2022 1 $0 4 Chief Accounting Officer 23 Mar 2022, 16:56
CNTA Centessa Pharmaceuticals plc 01 Feb 2022 1 $0 4 Chief Accounting Officer 03 Feb 2022, 17:30
CNTA Centessa Pharmaceuticals plc 02 Jun 2021 1 +$20,000 4 Chief Accounting Officer 04 Jun 2021, 17:00
CNTA Centessa Pharmaceuticals plc 27 May 2021 4 $0 4 Chief Accounting Officer 01 Jun 2021, 20:47
CNTA Centessa Pharmaceuticals plc 27 May 2021 0 $0 3 Chief Accounting Officer 27 May 2021, 20:25